Reading Time: 2 minutes
Hims & Hers Health (HIMS, i) has a short-selling rate of about 28.4%, making it one of the most shorted mid-caps in the healthcare sector. I am speculating on a potential short squeeze within the next few days and weeks for the following reasons. Hims & Hers is transforming into a comprehensive telemedicine platform with data advantages. A multi-agent system aims to support the entire patient journey. The new partnership with Novo Nordisk boosts GLP-1 demand with 125,000 Wegovy deliveries in 6 weeks. Hims & Hers is on track to achieve...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
